COR

Cencora, Inc

Healthcare


Presented:08/05/2024
Price:$240.73
Cap:$47.44B
Current Price:$233.12
Cap:$45.94B

Presented

Date08/05/2024
Price$240.73
Market Cap$47.44B
Ent Value$46.53B
P/E Ratio26.19x
Book Value$4.70
Div Yield0.84%
Shares O/S197.05M
Ave Daily Vol1,531,657
Short Int5.70%

Current

Price$233.12
Market Cap$45.94B
Cencora, Inc. is a pharmaceutical sourcing and distribution services company. It operates through the United States (U.S.) Healthcare Solutions and International Healthcare Solutions segments. The U.S. Healthcare Solutions segment focuses on the distribution of specialty, brand-name, and generic pharmaceuticals. The International Healthcare Solutions segment includes pharmaceutical wholesale, related operations, and global commercialization services. The company was founded by Emil P. Martini in 1947 and is headquartered in Conshohocken, PA.

Publicly traded companies mentioned herein: Cencora Inc (COR), Cigna Group/The (CI), Walgreens Boots Alliance Inc (WBA)

Highlights

The presenter is short shares of drug distributor Cencora Inc (COR), largely due to risks around its major contracts with Walgreens and Express Scripts. As such, he feels that a HSD% - LDD% earnings grower with meaningful overhangs should not support the current 16x EPS valuation implied by the $241 share price and the consensus forward EPS forecast of $14.88.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

  • Signing up and creating account with us unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Request access to DeMatteo Research for full access

Request Access

Already have an account?

Idea Discussion

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Commentor 1 - 2 weeks ago

Signing up and creating account with us, unlocks this content for you. Contact us today for full access to DeMatteo Research and more.

Idea Discussions display submitted commentary from our investor community.

To read and participate in the discussion with the presenter and investor base, request access to DeMatteo

Request Access

Already have an account?

An error occurred loading this content. Try again later or contact us.